Alzheimer's Disease and Antibodies: A Study on Immune Responses
Author Information
Author(s): Zhang Jiayuan, Wang Mingming, Wang Dong, Deng Linwen, Peng Yao
Hypothesis
Is there a causal link between antibody-mediated immune responses to infectious disease agents and the risk of Alzheimer's disease?
Conclusion
The study found that certain antibodies may protect against Alzheimer's disease, while others may increase the risk.
Supporting Evidence
- Varicella zoster virus glycoproteins E and I antibody levels are associated with a reduced risk of Alzheimer's disease.
- Higher levels of Epstein-Barr virus EBNA-1 antibody are linked to an increased risk of Alzheimer's disease.
Takeaway
Some antibodies can help protect against Alzheimer's disease, while others might make it more likely to happen.
Methodology
A two-sample Mendelian randomization analysis was conducted using genetic data from the UK Biobank and Finnish databases.
Potential Biases
The study did not exclude SNPs from the HLA region, which may influence AD risk.
Limitations
The study's findings may not be generalizable due to the population being predominantly of European ancestry and the potential for variability in antibody levels.
Participant Demographics
The study primarily involved individuals of European ancestry.
Statistical Information
P-Value
p<0.001
Confidence Interval
OR=0.8481 (CI: 0.8007–0.8983) for protective association; OR=1.0822 (CI: 1.0362–1.1303) for increased risk.
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website